Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes

Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes

Epstein-Barr virus (EBV) is a ubiquitous virus belonging to the human γ-herpes virus subfamily. After primary infection, EBV maintains a life-long latent infection. A major concern is that EBV can cause a diverse range of neoplasms and autoimmune diseases. In addition, patients undergoing h...

Full description

Bibliographic Details
Main Authors:	Ayumi Fujimoto, Ritsuro Suzuki
Format:	Article
Language:	English
Published:	MDPI AG 2020-02-01
Series:	Cancers
Subjects:	post-transplant lymphoproliferative disorder hematopoietic stem cell transplantation pathogenesis risk factors
Online Access:	https://www.mdpi.com/2072-6694/12/2/328

Similar Items

Haploidentical hematopoietic cell transplant recipient presents with late‐onset Epstein Barr virus‐associated posttransplant lymphoproliferative disorder
by: Adam Braun, et al.
Published: (2023-08-01)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
by: Masaaki Hotta, et al.
Published: (2018-05-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease
by: Paibel Aguayo-Hiraldo, et al.
Published: (2016-01-01)

Successful low‐dose chemotherapy for refractory Epstein‐Barr virus—related post‐transplant lymphoproliferative disorder following hematopoietic stem cell transplantation in a child with Wiskott‐Aldrich syndrome
by: Bixin Xi, et al.
Published: (2021-05-01)

Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options
by: Michele Clerico, et al.
Published: (2022-12-01)

Management of Epstein–Barr Virus Infection and Post-Transplant Lymphoproliferative Disorder in Pediatric Liver Transplantation
by: Tatsuya Okamoto, et al.
Published: (2022-04-01)

Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
by: Pascal Roland Enok Bonong, et al.
Published: (2021-03-01)

Characteristics, management, and outcome of pediatric patients with post‐transplant lymphoproliferative disease—A 20 years' experience from Austria
by: Anna Füreder, et al.
Published: (2021-10-01)

Lymphoproliferative disorder after kidney transplantation
by: Petrović Lada, et al.
Published: (2018-01-01)

Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature
by: Xueqing Yang, et al.
Published: (2024-02-01)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
by: Ana Marcela Rojas Fonseca-Hial, et al.
Published: (2016-06-01)

Epstein-Barr Virus-Negative Post-Transplant Lymphoproliferative Diseases: Three Distinct Cases from a Single Center
by: Şule Mine Bakanay, et al.
Published: (2014-02-01)

Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients
by: Heloisa Helena de Sousa Marques, et al.
Published: (2014-10-01)

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Ting-Ting Yang, et al.
Published: (2021-04-01)

Epstein–Barr virus-positive lymphoproliferative disorder manifesting as pulmonary disease in a patient with acute myeloid leukemia: a case report
by: Ritika Dutta, et al.
Published: (2021-03-01)

Late Onset Epstein Barr Virus Seropositive Posttransplant Lymphoproliferative Disorder in Two Renal Transplant Receivers
by: Saime Paydaş, et al.
Published: (2013-09-01)

Epstein-Barr virus induced post-transplant lymphoproliferative disorder presenting with unilateral retinal involvement
by: Mainguy Adam, et al.
Published: (2021-09-01)

Hematopoietic cell transplantation for asymptomatic X-linked lymphoproliferative syndrome type 1
by: Akihiro Tamura, et al.
Published: (2018-11-01)

18F-FDG PET/CT findings in a patient with blastic plasmacytoid dendritic cell neoplasm and post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: a case report
by: Jinzhi Chen, et al.
Published: (2023-08-01)

Post-transplant lymphoproliferative disease after liver transplantation
by: Jose-Ignacio Herrero, et al.

Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report
by: Ryoichi Goto, et al.
Published: (2020-06-01)

Diagnostic Challenge in Renal Transplantation: Splenosis vs. Post-Transplant Lymphoproliferative Disorder—A Case Report
by: Jes M. Sanders, et al.
Published: (2023-09-01)

Comparison of Post-Transplantation Lymphoproliferative Disorder Risk and Prognostic Factors between Kidney and Liver Transplant Recipients
by: Krzysztof Mucha, et al.
Published: (2022-04-01)

Dermoscopic features of cutaneous post-transplant lymphoproliferative disorder in a renal transplant recipient
by: Hua Xian Elizabeth Wang, MBBS, et al.
Published: (2022-09-01)

Early post-transplant lymphoproliferative disorder - case of fatal lymphoma after kidney transplantation
by: Laušević Mirjana, et al.
Published: (2016-01-01)

Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes
by: Apostolia Papalexandri, et al.
Published: (2023-11-01)

Primary cutaneous post liver transplant lymphoproliferative disorder (PTLD) successfully treated with radiotherapy
by: Aizuri Murad, et al.
Published: (2018-02-01)

Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder
by: Mariam Markouli, et al.
Published: (2022-12-01)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
by: Mohsen eNavari, et al.
Published: (2014-12-01)

Post-transplant lymphoproliferative disease after pediatric kidney transplant
by: Rosanna Fulchiero, et al.
Published: (2022-12-01)

Post-transplant lymphoproliferative disorder: Case reports of three children with kidney transplant
by: Spasojević-Dimitrijeva Brankica, et al.
Published: (2014-01-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy
by: Hiroaki Inoue, et al.
Published: (2020-04-01)

Painful angiomyxoid tumor in a failed renal allograft presenting as post-transplant lymphoproliferative disorder
by: Paulette Cutruzzula Dreher, et al.
Published: (2020-04-01)

A Survival of Post-transplant Lymphoproliferative Disorder after Kidney Transplantation in Patients under Rapamycin Treatment
by: Farzaneh Ashrafi, et al.
Published: (2021-10-01)

A retrospective study and clinical analysis of post-transplant lymphoproliferative disorder
by: LIU Yanquan, HU Xiaomei, YIN Yue, LIN Lin, SHEN Jianzhen, CHEN Yuting, TANG Huanwen
Published: (2022-07-01)

The use of non-cryopreserved hematopoietic stem cells for autologous transplantation in multiple myeloma patients
by: S. V. Voloshin, et al.
Published: (2022-04-01)

CASE 2–2012: a 57-Year-Old Woman with Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
by: Milan Košťál, et al.
Published: (2012-01-01)

The spectrum of Epstein-Barr virus infections of the central nervous system after organ transplantation
by: Mohamed Ridha, et al.
Published: (2021-08-01)